Electromed: Possible Catalyst For A Positive Re-Rating
- Electromed sells a competitive medical device meant for airway clearance.
- This medical device is analogous to what Baxter delivers in the peritoneal dialysis market, only for airway clearance.
- Electromed has launched a new model and is seeing accelerated revenue growth. Electromed is also near attaining profitability.
- It seems to me that Electromed shares will re-rate higher as the market sees the growth and likely profitability for a seller of an high-margin medical device.